Log in to search using one of your social media accounts:

 

Primary biliary cirrhosis
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - May 16, 2017 Category: Consumer Health News Source Type: news

New pill spares women trauma of liver transplant
In the UK, 20,000 people – 90 per cent of them women – suffer from primary biliary cholangitis, also known as primary biliary cirrhosis (PBC). (Source: the Mail online | Health)
Source: the Mail online | Health - May 13, 2017 Category: Consumer Health News Source Type: news

PBC can present asymptomatically in elderly patients
An 83-year-old woman who was admitted to an emergency department for unsteadiness and dizziness was eventually diagnosed with primary biliary cirrhosis (PBC), according to a case report by Patrice... (Source: Family Practice News)
Source: Family Practice News - July 28, 2016 Category: Primary Care Source Type: news

Poor outcome for PBC patient with bullous pemphigoid
A 45-year-old woman who was admitted with concurrent primary biliary cirrhosis or cholangitis (PBC) and bullous pemphigoid died 5 days after admittance, according to a case report from N.B. Guerra-Uribe, MD, and M.S. González-Huezo, MD. The patient was admitted to the emergency department for... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 29, 2016 Category: Dermatology Source Type: news

Hepatocellular carcinoma risk quantified in PBC patients
Biochemical nonresponse was the most significant predictor of future risk for developing hepatocellular carcinoma among an international cohort of patients with primary biliary cirrhosis (PBC). In a... (Source: Family Practice News)
Source: Family Practice News - May 16, 2016 Category: Primary Care Source Type: news

FDA Advisory Committee Unanimously Recommends Accelerated Approval of Ocaliva (obeticholic acid) for the Treatment of Primary Biliary Cirrhosis
NEW YORK, April 07, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 10, 2016 Category: Drugs & Pharmacology Source Type: news

Primary biliary cirrhosis: case study
A case of primary biliary cirrhosis discovered during routine liver function tests, highlights the symptoms to look out for. (Source: GP Online Education)
Source: GP Online Education - February 25, 2016 Category: Primary Care Tags: 15.2 Digestive Problems Source Type: news

Fast Forward begins two Phase II trials of FFP104 in PBC and Crohn’s disease patients
Fast Forward Pharmaceuticals has started two Phase II clinical trials of FFP104, a potential treatment for patients with primary biliary cirrhosis (PBC) and Crohn's disease. (Source: Drug Development Technology)
Source: Drug Development Technology - February 4, 2016 Category: Pharmaceuticals Source Type: news

New Scoring System Predicts Transplant-Free Survival in PBC (CME/CE)
(MedPage Today) -- GLOBE outperforms other criteria as prognosticator in primary biliary cirrhosis (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - September 15, 2015 Category: Gastroenterology Source Type: news

FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis
NEW YORK, Aug. 31, 2015 -- (Healthcare Sales & Marketing Network) -- Intercept Pharmaceuticals, Inc. (ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic unde... Biopharmaceuticals, FDAIntercept Pharmaceuticals, obeticholic acid, cirrhosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2015 Category: Pharmaceuticals Source Type: news

Primary Biliary Cirrhosis
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 25, 2015 Category: Journals (General) Source Type: news

Mayo Clinic Q and A: Medication may help slow progression of PBC
DEAR MAYO CLINIC: I was diagnosed with primary biliary cirrhosis three months ago. I don’t have any symptoms yet but wonder what I should look for. Are there things I can do to slow its progression? ANSWER: Your situation is common. Most people diagnosed with primary biliary cirrhosis, or PBC, in its early stages do [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 6, 2015 Category: Databases & Libraries Source Type: news

New Drug Boosts Response in Primary Biliary Cirrhosis (CME/CE)
(MedPage Today) -- Called obeticholic acid, the investigational agent is a farnesoid X receptor agonist. (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 20, 2015 Category: Gastroenterology Source Type: news

PBC Patients Face High Wait-List Mortality (CME/CE)
(MedPage Today) -- Consider allocation of exception MELD points to primary biliary cirrhosis patients on transplant list. (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 18, 2015 Category: Gastroenterology Source Type: news

Alkaline Phosphatase, Bilirubin Levels and Outcomes in PBCAlkaline Phosphatase, Bilirubin Levels and Outcomes in PBC
Do alkaline phosphatase and bilirubin levels help clinicians predict disease outcome in patients with primary biliary cirrhosis? Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 20, 2015 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Finding the Patient With Primary Biliary CirrhosisFinding the Patient With Primary Biliary Cirrhosis
If you don't consider it, you might miss the diagnosis of this slowly progressive autoimmune disorder. Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 28, 2015 Category: Gastroenterology Tags: Gastroenterology Expert Column Source Type: news

Researchers wind up a 40 year old debate on betaretrovirus infection in humans
New light has been shed on primary biliary cirrhosis, a rare liver disease that affects up to one in 500 middle aged women. In a study, researchers demonstrate that patients with the disease are infected with human betaretrovirus -- a virus resembling a mouse mammary tumor virus. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 19, 2015 Category: Science Source Type: news

UAlberta researchers wind up a 40-year-old debate on betaretrovirus infection in humans
(University of Alberta Faculty of Medicine & Dentistry) Research from the University of Alberta is shedding new light on primary biliary cirrhosis, a rare liver disease that affects up to one in 500 middle-aged women. In a study published in the journal Alimentary Pharmacology and Therapeutics, Andrew Mason, a professor of medicine in the Department of Medical Microbiology and Immunology, proves that patients with the disease are infected with human betaretrovirus -- a virus resembling a mouse mammary tumor virus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2015 Category: Global & Universal Source Type: news

New liver gives mother of three a life without pain
Mrs. Linss’ medical problem was diagnosed as primary biliary cirrhosis (PBC), a disease in which the bile ducts are damaged, causing bile to build up in the liver. (Source: UT Southwestern Medical Center News)
Source: UT Southwestern Medical Center News - November 20, 2014 Category: Hospital Management Source Type: news

Intercept Announces Additional Data for OCA in Primary Biliary Cirrhosis
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - November 9, 2014 Category: Pharmaceuticals Source Type: news

Primary Biliary Cirrhosis (PBC)
Title: Primary Biliary Cirrhosis (PBC)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 4/23/2014 2:58:18 PM (Source: MedicineNet Crohn's Disease General)
Source: MedicineNet Crohn's Disease General - April 23, 2014 Category: Gastroenterology Source Type: news

Obeticholic Acid Tx Tied to Clinical Benefit in PBC
LONDON (MedPage Today) -- The investigational compound obeticholic acid holds promise for people with primary biliary cirrhosis (PBC) -- the first new potential treatment in 2 decades, a researcher said here. (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - April 13, 2014 Category: Gastroenterology Source Type: news

New Compound Tied to Clinical Benefit in PBC
LONDON (MedPage Today) -- The investigational compound obeticholic acid holds promise for people with primary biliary cirrhosis (PBC) -- the first new potential treatment in 2 decades, a researcher said here. (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - April 13, 2014 Category: Gastroenterology Source Type: news

Primary Biliary Cirrhosis Drug Effective in Late-Stage TrialPrimary Biliary Cirrhosis Drug Effective in Late-Stage Trial
Intercept Pharmaceuticals said its experimental drug for primary biliary cirrhosis, obeticholic acid (OCA), was effective in a third late-stage clinical trial and that the results set the stage for the company to file for marketing approval. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2014 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Primary Biliary Cirrhosis
Title: Primary Biliary CirrhosisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/9/2014 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 9, 2014 Category: Nutrition Source Type: news

Assessing the Effect of Simvastatin in PBCAssessing the Effect of Simvastatin in PBC
Is simvastatin an effective drug therapy in the treatment of primary biliary cirrhosis? Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2013 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Celiac Disease and Primary Biliary Cirrhosis: An Immune LinkCeliac Disease and Primary Biliary Cirrhosis: An Immune Link
What do scientists know about the connection between celiac disease and primary biliary cirrhosis, and how does this knowledge translate into treatement strategies for both diseases? Expert Review of Gastroenterology and Hepatology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 3, 2013 Category: Gastroenterology Tags: Gastroenterology Journal Article Source Type: news

Early PBC prognosis advocated
Biochemical response to ursodeoxycholic acid at 6 months is a better predictor for primary biliary cirrhosis prognosis than the current standard of 1 year, study results suggest. (Source: MedWire News - Gastroenterology)
Source: MedWire News - Gastroenterology - February 19, 2013 Category: Gastroenterology Source Type: news